Multiomics Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research, a renowned market research firm, has recently released a comprehensive report on the global Multiomics Market. This in-depth analysis provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. The report offers an extensive overview of the multiomics landscape, featuring exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The global multiomics market is forecast to expand at a CAGR of 14.2% and thereby increase from a value of US$2.1 Bn in 2023, to US$5.3 Bn by the end of 2030.

Key Insights:

Multiomics Market Size (2023): US$2.1 Billion
Projected Market Value (2030): US$5.3 Billion
Global Market Growth Rate (CAGR 2023 to 2030): 14.2%
Historical Market Growth Rate (CAGR 2018 to 2022): 10.2%

Multiomics Market - Report Scope:

The Multiomics Market is poised for significant growth, driven by advancements in omics technologies, the integration of multiomics data in precision medicine, and the rising demand for comprehensive molecular insights. This market serves researchers, pharmaceutical companies, healthcare providers, and diagnostic laboratories, offering multiomics solutions for genomics, proteomics, metabolomics, and other molecular analyses. Market growth is fueled by the increasing complexity of disease understanding, the need for personalized therapeutic approaches, and ongoing research and development in molecular biology.

Market Growth Drivers:

The global Multiomics Market benefits from several key growth drivers. Advances in high-throughput sequencing technologies, mass spectrometry, and bioinformatics enable the simultaneous analysis of multiple biological data types, providing a holistic view of molecular processes. The integration of multiomics data facilitates a deeper understanding of complex diseases, drug responses, and the identification of biomarkers for precision medicine. Moreover, collaborative efforts in research and the application of multiomics in diverse fields, including oncology, neurology, and infectious diseases, drive market growth. The market is also influenced by the increasing adoption of multiomics approaches in drug discovery and development.

Market Restraints:

Despite promising growth prospects, the Multiomics Market faces challenges related to data integration, standardization, and the complexity of multiomics analyses. Integrating data from genomics, transcriptomics, proteomics, and metabolomics poses computational and analytical challenges, impacting the interpretation and reproducibility of results. Standardizing multiomics workflows and ensuring data quality and accuracy are essential for reliable outcomes. Additionally, the need for skilled professionals, robust bioinformatics infrastructure, and ethical considerations in handling patient data pose challenges for market adoption. Addressing these challenges requires collaborative efforts between technology developers, researchers, and regulatory bodies to establish best practices and guidelines.

Market Opportunities:

The Multiomics Market presents significant growth opportunities driven by ongoing research, technological innovations, and the integration of multiomics in clinical practice. The development of integrated platforms and tools that streamline multiomics workflows and data analysis enhances accessibility and usability. Furthermore, strategic collaborations, partnerships, and the expansion of multiomics applications in areas such as microbiomics and epigenomics open new avenues for market players to capitalize on emerging opportunities and maintain a competitive edge.

Key Questions Answered in the Report:

What is the Forecast CAGR of the Global Multiomics Market?
What was the Market Size of the Market in 2023?
Which Country Held the Largest Market Share in 2023?
Who are the Key Players in the Global Multiomics Market?
Which is the Fastest-growing End User Segment in Global Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Multiomics Market, including [Insert Key Companies], focus on innovation, platform integration, and strategic collaborations to gain a competitive edge. These companies invest in the development of integrated multiomics solutions, user-friendly interfaces, and cloud-based data storage and analysis platforms. Collaborations with research institutions, pharmaceutical companies, and healthcare providers facilitate market access and improve the adoption of multiomics technologies. Moreover, emphasis on education, training, and the promotion of data standardization fosters market growth and advances the use of multiomics in precision medicine and molecular diagnostics.

Key Companies Profiled:

BD
Thermo Fisher Scientific Inc.
Illumina, Inc
Danaher
PerkinElmer Inc.
Shimadzu Corporation
Bruker
QIAGEN
Agilent Technologies, Inc.
BGI

Multiomics Market Research Segmentation:

The multiomics market is experiencing significant growth, with instruments emerging as the dominant category due to their pivotal role in data generation across various omics domains. Advanced technologies in genomics and proteomics heavily rely on sophisticated instruments like next-generation sequencers and mass spectrometers. Software is the fastest-growing category, driven by the increasing need for advanced bioinformatics tools and data analysis solutions to handle the complexity of multiomics data.

Bulk multiomics is the primary type, dominating due to its efficiency in handling large sample volumes and simultaneous analysis of multiple omics layers. Single-cell multiomics is the fastest-growing category, allowing precise analysis at the individual cell level, unraveling complex biological phenomena.

Oncology is the largest application area, driven by the demand for comprehensive molecular insights into cancer biology. Neurology is the fastest-growing category, addressing the intricate molecular mechanisms underlying neurological disorders.

Pharmaceutical and biotech firms are leading end users, extensively utilizing multiomics technologies for drug discovery. Academic and research institutes are the fastest-growing category, contributing significantly to multiomics applications.

In regional markets, Europe dominates with a strong scientific landscape, robust infrastructure, and substantial R&D investments, emphasizing precision medicine. South Asia and the Pacific emerge as the fastest-growing region, driven by technological adoption, expanding healthcare infrastructure, and increased research collaborations.

By Product and Service:

Products
Instruments
Consumables
Software
Services

By Type:

Single-cell Multiomics
Bulk Multiomics

By Application:

Cell Biology
Oncology
Neurology
Immunology

By End-use:

Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Others

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33840

1. Executive Summary

1.1. Global Multiomics Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product and Service Lifecycle Analysis
2.4. Multiomics Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Multiomics Market Outlook: Product and Service
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product and Service, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
  - 3.3.3.1. Products
  - 3.3.3.2. Instruments
  - 3.3.3.3. Consumables
  - 3.3.3.4. Software
  - 3.3.3.5. Services
3.4. Market Attractiveness Analysis: Product and Service
3.5. Global Multiomics Market Outlook: Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
  - 3.5.3.1. Single-cell Multiomics
  - 3.5.3.2. Bulk Multiomics
3.6. Market Attractiveness Analysis: Type
3.7. Global Multiomics Market Outlook: Application
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.7.3.1. Cell Biology
  - 3.7.3.2. Oncology
  - 3.7.3.3. Neurology
  - 3.7.3.4. Immunology
3.8. Market Attractiveness Analysis: Application
3.9. Global Multiomics Market Outlook: End User
- 3.9.1. Introduction / Key Findings
- 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.9.3.1. Academic and Research Institutes
  - 3.9.3.2. Pharmaceutical & biotechnology companies
  - 3.9.3.3. Others
3.10. Market Attractiveness Analysis: End User

4. Global Multiomics Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product and Service
- 5.3.3. By Type
- 5.3.4. By Application
- 5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
- 5.5.1. Products
- 5.5.2. Instruments
- 5.5.3. Consumables
- 5.5.4. Software
- 5.5.5. Services
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 5.6.1. Single-cell Multiomics
- 5.6.2. Bulk Multiomics
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.7.1. Cell Biology
- 5.7.2. Oncology
- 5.7.3. Neurology
- 5.7.4. Immunology
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.8.1. Academic and Research Institutes
- 5.8.2. Pharmaceutical & biotechnology companies
- 5.8.3. Others
5.9. Market Attractiveness Analysis

6. Europe Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product and Service
- 6.3.3. By Type
- 6.3.4. By Application
- 6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
- 6.5.1. Products
- 6.5.2. Instruments
- 6.5.3. Consumables
- 6.5.4. Software
- 6.5.5. Services
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 6.6.1. Single-cell Multiomics
- 6.6.2. Bulk Multiomics
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.7.1. Cell Biology
- 6.7.2. Oncology
- 6.7.3. Neurology
- 6.7.4. Immunology
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.8.1. Academic and Research Institutes
- 6.8.2. Pharmaceutical & biotechnology companies
- 6.8.3. Others
6.9. Market Attractiveness Analysis

7. East Asia Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product and Service
- 7.3.3. By Type
- 7.3.4. By Application
- 7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
- 7.5.1. Products
- 7.5.2. Instruments
- 7.5.3. Consumables
- 7.5.4. Software
- 7.5.5. Services
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 7.6.1. Single-cell Multiomics
- 7.6.2. Bulk Multiomics
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.7.1. Cell Biology
- 7.7.2. Oncology
- 7.7.3. Neurology
- 7.7.4. Immunology
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.8.1. Academic and Research Institutes
- 7.8.2. Pharmaceutical & biotechnology companies
- 7.8.3. Others
7.9. Market Attractiveness Analysis

8. South Asia & Oceania Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product and Service
- 8.3.3. By Type
- 8.3.4. By Application
- 8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
- 8.5.1. Products
- 8.5.2. Instruments
- 8.5.3. Consumables
- 8.5.4. Software
- 8.5.5. Services
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 8.6.1. Single-cell Multiomics
- 8.6.2. Bulk Multiomics
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.7.1. Cell Biology
- 8.7.2. Oncology
- 8.7.3. Neurology
- 8.7.4. Immunology
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.8.1. Academic and Research Institutes
- 8.8.2. Pharmaceutical & biotechnology companies
- 8.8.3. Others
8.9. Market Attractiveness Analysis

9. Latin America Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product and Service
- 9.3.3. By Type
- 9.3.4. By Application
- 9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
- 9.5.1. Products
- 9.5.2. Instruments
- 9.5.3. Consumables
- 9.5.4. Software
- 9.5.5. Services
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 9.6.1. Single-cell Multiomics
- 9.6.2. Bulk Multiomics
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.7.1. Cell Biology
- 9.7.2. Oncology
- 9.7.3. Neurology
- 9.7.4. Immunology
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.8.1. Academic and Research Institutes
- 9.8.2. Pharmaceutical & biotechnology companies
- 9.8.3. Others
9.9. Market Attractiveness Analysis

10. Middle East & Africa Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product and Service
- 10.3.3. By Type
- 10.3.4. By Application
- 10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
- 10.5.1. Products
- 10.5.2. Instruments
- 10.5.3. Consumables
- 10.5.4. Software
- 10.5.5. Services
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 10.6.1. Single-cell Multiomics
- 10.6.2. Bulk Multiomics
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.7.1. Cell Biology
- 10.7.2. Oncology
- 10.7.3. Neurology
- 10.7.4. Immunology
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.8.1. Academic and Research Institutes
- 10.8.2. Pharmaceutical & biotechnology companies
- 10.8.3. Others
10.9. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Instruments
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. BD
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Thermo Fisher Scientific Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Illumina, Inc
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Danaher
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. PerkinElmer Inc.
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Shimadzu Corporation
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Bruker
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. QIAGEN
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Agilent Technologies, Inc.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. BGI
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations